519.
Tandon, B. N., Das, B. C., Saraya, A. K., and Deo, M. G. (1966) . British Medical Journal, 1, 714. Tandon, B. N., Das, B. C., Saraya, A. K., Ramachandran, K., and Sama, S. K. (1969) . Gut, 10, 360. Watson, W. C., Paton, E., and Murray, D. (1965) . Lancet, 2, 47.
Zalusky, R., and Herbert, V. (1961 (O'Meara, 1958) and their vascularization and growth require a fibrin network as a matrix (see Laki and Yancey, 1968) . A neoplasm may also possess fibrinolytic activity (Cliffton and Grossi, 1955; Thornes, 1967; Peterson et al., 1968; Davidson et al., 1969; Bock et al., 1970 The purpose of the present investigation was to find out whether the finding of F.D.P. might be of diagnostic value in patients with clinically suspect ovarian tumour.
Patients and Methods
The clinical material consisted of 163 women in whom palpation at gynaecological examination gave reason to suspect ovarian tumours. Blood samples were obtained for determination of F.D.P. The patients were afterwards examined by laparoscopy or subjected to laparotomy. Biopsy specimens and operative specimens were afterwards examined histologically and classified. Also ascitic fluid, when found, was examined for
Collection of Blood.-Blood was collected in tubes containing an inhibitor of fibrinolysis, aminocaproic acid, to avoid in-vitro fibrinolysis, as well as thrombin to prevent incomplete coagulation with residual fibrinogen. Serum from these samples was prepared in the way described by Nilehn (1967 Only six patients with benign conditions had demonstrable F.D.P. (Table II) . Of these, one patient with endometriosis showed signs of bleeding and another had a myoma with degenerative changes. Laki and Yancey (1968) suggested that the clotting enzyme in tumour extracts was thrombin. These authors believe that a fibrin network is necessary for the vascularization and growth of tumours. Cliffton and Grossi (1955) (Table I) . These tumours have a high content of plasma proteins (Kjellgren, 1967) . The serous cystadenocarcinomas which were not associated with demonstrable F.D.P. were all well defined and showed no gross or microscopical signs of penetration of the capsule.
F.D.P. were also found in some of the patients with benign changes (Table II) . In the patient with endometriosis there were, however, fresh bleedings which might explain the occurrence of F.D.P. In eosinophilic myometritis there is often concealed allergy. Robbins and Stetson (1959) believed that all antigen-antibody reactions can cause an intravascular deposition of fibrin. In one case there was sepsis, a condition in which F.D.P. are nearly always found (Hedner and Nilsson, 1971) . In the woman with rayoma there were degenerative changes with fibrin deposits.
Of the patients with malignant tumours, then, F.D.P. were found in 72%. In those with benign changes F.D.P. were found in 4 5%, and in most of these the occurrence of F.D.P. could be explained on some other clinical ground. This suggests that examination for F.D.P. in patients with suspected malignant ovarian tumours may be of diagnostic value. Absence of demonstrable F.D.P. does not exclude malignancy. The occurrence of F.D.P. does, however, lend support to a provisional diagnosis of malignant disease and indicates further investigation.
It is debatable whether the occurrence of F.D.P. is due to extravascular breakdown of fibrin by tumour cells-a possibility suggested by the high values found in the ascitic fluid-and/or to thromboplastic and fibrinolytic agents from the tumour entering the blood stream.
